← Eichor
Condition: Clad Bronchiolitis Obliterans Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Clad Bronchiolitis Obliterans

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

LAM-001 in Lung Transplant Recipients With Bronchiolitis Obliterans Syndrome.
Phase 2 · 1 location(s) · Steven Hays, MD · NCT06018766Belumosudil to Block Chronic Lung Allograft Dysfunction (CLAD) in High Risk Lung Transplant Recipients
Phase 2 · 12 location(s) · National Institute of Allergy and Infectious Diseases (NIAID · NCT06476132Plasma and Radiologic Biomarkers of Response to ECP in Lung Transplant Recipients With CLAD
Phase N/A · 3 location(s) · Brian Keller · NCT07434869
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.